Phossy jaw

Last updated

Phossy jaw, formally known as phosphorus necrosis of the jaw, was an occupational disease affecting those who worked with white phosphorus (also known as yellow phosphorus) without proper safeguards. It is also likely to occur as the result of use of chemical weapons that contain white phosphorus. It was most commonly seen in workers in the matchstick industry in the 19th and early 20th centuries. [1] It was caused by white phosphorus vapor, which destroys the bones of the jaw. Modern occupational hygiene practices have since eliminated the working conditions that caused this disease. [1]

Contents

Symptoms

Those with phossy jaw would usually begin suffering painful toothaches and swelling of the gums. The pain was characterized as "persistent yet progressive ... spreading to neighboring teeth and jawbone". [2] Over time, pus formation developed penetrating the oral mucosa with the formation of fistula, tooth loss, and recurrent abscesses. [2] Further progression led to the formation of sequestrum (dead bone that has separated from living bone) after three months and necrosis of the jaw within six months. [2] The distinguishing feature of this disease was the eventual separation of the sequestrum which was described as porous and light in weight. [1] [3] The lower jaw was more commonly affected than the upper jaw. [3] Affected bones glowed a greenish-white colour in the dark. [4] [5] The condition also affected the brain, provoking seizures in some chronic cases. [6]

Treatment

Treatments included topical antimicrobials, conservative debridement of sequestra and surgery. [7] Surgical removal of the afflicted jaw bones could save the patient; otherwise, death from organ failure would follow. The disease was extremely painful and disfiguring to the patient, with dying bone tissue rotting away accompanied by a foul-smelling discharge. Removal of the jaw bone also had serious effects on patients' ability to eat, leading to further health concerns including malnutrition.

Diagnostic imaging

The clinical features appear first, pain in the teeth and jaw, abscesses, etc. as described above. Once the clinical changes occur and the problem is made known a doctor or dentist could see changes in the jaw bones through radiographs or X-rays. The sequestra, the parts of the bone that die and break off, are light in weight and yellow to brown in color. Thus phossy jaw can be clearly demarcated from similar entities by radiographs. In radiographs, the sequestra present a typical worm-eaten appearance similar to a pumice stone. Sequestra appear osteoporotic and decalcified. Separation of the dead bone from the surrounding bone appears clearly demarcated in the radiographs. [1]

History

Discovery

The first case of phossy jaw was diagnosed in 1839 by Friedrich Wilhelm Lorinser, a doctor in Vienna. [8] The patient was a female Viennese matchstick maker who had been exposed to the phosphorus vapors over a five-year period. [9] [10] He named the disease "Phosphorimus chronicus". [2] In 1844 Lorinser reported 22 cases of phossy jaw and established the toxic effects of white phosphorus in matchsticks. [11]

International and national legislation and public organisations

Europe

In 1872, the Grand Duchy of Finland, part of the Russian Empire, was the first country to place an absolute ban on the manufacture, use and sale of white phosphorus in matches; this was followed by Denmark in 1874 and France in 1897. In Great Britain, a ban on white phosphorus matches became effective on 1 January 1910. [9] [11] The international association for labor legislation, an international conference, met at Berne, Switzerland, in 1906 and pledged to prohibit the manufacture, importation and sale of white phosphorus matches. This treaty was signed by Finland, Denmark, France, Switzerland, Luxembourg, Italy, the Netherlands and Germany, in what is considered as the first international attempt to ban an industrial product. [9] [11] [12]

United States

Phossy jaw was publicized by the American Association for Labor Legislation, whose secretary, John B. Andrews, began investigating the disease in 1909 and found more than 100 cases. This report was published in the Bulletin of the Bureau of Labor. The White Phosphorus Match Act of 1912, signed by President William Howard Taft on April 9, 1912, required manufacturers who used white phosphorus to register with district collectors of internal revenue and to file periodic notices and returns, levied a tax of two cents per hundred matches and required makers of white-phosphorus matches to affix revenue stamps to the matchboxes. [9] [11] [12]

Asia

Russia placed a heavy tax on white phosphorus matches in 1892 which was doubled in 1905. By 1906, the production of white phosphorus matches had been reduced to one match in every fifty. [9] India and Japan banned the use of white phosphorus in 1919 after the United States, followed by China's ban on white phosphorus usage in match production in 1925. [11]

Match industry

White phosphorus was the active ingredient of most matches from the 1840s to the 1910s. Concern over phossy jaw contributed to the London matchgirls strike of 1888, and although this strike did not end the use of white phosphorus, William Booth and The Salvation Army opened a match-making factory in 1891 that used the much safer, though more expensive, red phosphorus. [13] The Salvation Army also campaigned with local retailers to get them to sell only red phosphorus matches. [13]

However it was not until the use of white phosphorus was prohibited by the international Berne Convention in 1906 and its provisions were implemented in national laws over the next few years that industrial use ceased. [14]

Mechanism of action of white phosphorus

In phossy jaw patients, the forensic evidence suggested the conversion of yellow phosphorus to potent amino bisphosphonates by natural chemical reactions in the human body. Yellow phosphorus has a simple chemistry; when combined with H2O and CO2 molecules from respiration and some amino acids such as lysine, bisphosphonates result. [3]

A related condition, medication related osteonecrosis of the jaw (MRONJ), has been described as a side-effect of amino-bisphosphonates, a class of phosphorus-based drugs that inhibit bone resorption and are used widely for treating osteoporosis, bone disease in cancer and some other conditions. [15] BON, sometimes called "bis-phossy jaw", [16] is primarily associated with the use of intravenous bisphosphonates in the treatment of cancer. The percentage incidence of BON from this use is approximately 1000 times higher than the incidence of BON caused by the use of oral bisphosphonates. [17]

See also

Related Research Articles

<span class="mw-page-title-main">Bisphosphonate</span> Pharmaceutical drugs for preventing bone loss

Bisphosphonates are a class of drugs that prevent the loss of bone density, used to treat osteoporosis and similar diseases. They are the most commonly prescribed drugs used to treat osteoporosis. They are called bisphosphonates because they have two phosphonate groups. They are thus also called diphosphonates.

<span class="mw-page-title-main">Alendronic acid</span> Chemical compound

Alendronic acid, sold under the brand name Fosamax among others, is a bisphosphonate medication used to treat osteoporosis and Paget's disease of bone. It is taken by mouth. Use is often recommended together with vitamin D, calcium supplementation, and lifestyle changes.

<span class="mw-page-title-main">Avascular necrosis</span> Death of bone tissue due to interruption of the blood supply

Avascular necrosis (AVN), also called osteonecrosis or bone infarction, is death of bone tissue due to interruption of the blood supply. Early on, there may be no symptoms. Gradually joint pain may develop, which may limit the person's ability to move. Complications may include collapse of the bone or nearby joint surface.

<span class="mw-page-title-main">Orthognathic surgery</span> Surgery of the jaw

Orthognathic surgery, also known as corrective jaw surgery or simply jaw surgery, is surgery designed to correct conditions of the jaw and lower face related to structure, growth, airway issues including sleep apnea, TMJ disorders, malocclusion problems primarily arising from skeletal disharmonies, and other orthodontic dental bite problems that cannot be treated easily with braces, as well as the broad range of facial imbalances, disharmonies, asymmetries, and malproportions where correction may be considered to improve facial aesthetics and self-esteem.

<span class="mw-page-title-main">Dental extraction</span> Operation to remove a tooth

A dental extraction is the removal of teeth from the dental alveolus (socket) in the alveolar bone. Extractions are performed for a wide variety of reasons, but most commonly to remove teeth which have become unrestorable through tooth decay, periodontal disease, or dental trauma, especially when they are associated with toothache. Sometimes impacted wisdom teeth cause recurrent infections of the gum (pericoronitis), and may be removed when other conservative treatments have failed. In orthodontics, if the teeth are crowded, healthy teeth may be extracted to create space so the rest of the teeth can be straightened.

<span class="mw-page-title-main">Dentinogenesis imperfecta</span> Genetic disorder impairing tooth development

Dentinogenesis imperfecta (DI) is a genetic disorder of tooth development. It is inherited in an autosomal dominant pattern, as a result of mutations on chromosome 4q21, in the dentine sialophosphoprotein gene (DSPP). It is one of the most frequently occurring autosomal dominant features in humans. Dentinogenesis imperfecta affects an estimated 1 in 6,000-8,000 people.

<span class="mw-page-title-main">Matchgirls' strike</span> 1888 labour dispute in the UK

In July 1888, the women and teenage girls working at the Bryant & May match factory in Bow, London, England went on strike. At first, the strikers were protesting the dismissal of a worker after employees had refused a demand from Bryant & May management to repudiate an article on terrible working conditions at the factory. When management promised to rehire the fired worker, the strikers continued the industrial action to bargain for a cessation of unfair deductions from pay and for other improvements to working conditions. With the help of social activist Annie Besant, they succeeded.

<span class="mw-page-title-main">Osteonecrosis of the jaw</span> Medical condition

Osteonecrosis of the jaw (ONJ) is a severe bone disease (osteonecrosis) that affects the jaws. Various forms of ONJ have been described since 1861, and a number of causes have been suggested in the literature.

<span class="mw-page-title-main">Central giant-cell granuloma</span> Medical condition

Central giant-cell granuloma (CGCG) is a localised benign condition of the jaws. It is twice as common in females and is more likely to occur before age 30. Central giant-cell granulomas are more common in the anterior mandible, often crossing the midline and causing painless swellings.

<span class="mw-page-title-main">Medication-related osteonecrosis of the jaw</span> Medical condition

Medication-related osteonecrosis of the jaw is progressive death of the jawbone in a person exposed to a medication known to increase the risk of disease, in the absence of a previous radiation treatment. It may lead to surgical complication in the form of impaired wound healing following oral and maxillofacial surgery, periodontal surgery, or endodontic therapy.

Neuralgia-inducing cavitational osteonecrosis (NICO) is a diagnosis whereby a putative jawbone cavitation causes chronic facial neuralgia; this is different from osteonecrosis of the jaw. In NICO the pain is said to result from the degenerating nerve ("neuralagia"). The condition is probably rare, if it does exist.

<span class="mw-page-title-main">Mandibular fracture</span> Medical condition

Mandibular fracture, also known as fracture of the jaw, is a break through the mandibular bone. In about 60% of cases the break occurs in two places. It may result in a decreased ability to fully open the mouth. Often the teeth will not feel properly aligned or there may be bleeding of the gums. Mandibular fractures occur most commonly among males in their 30s.

<span class="mw-page-title-main">Jaw abnormality</span> Medical condition

A jaw abnormality is a disorder in the formation, shape and/or size of the jaw. In general abnormalities arise within the jaw when there is a disturbance or fault in the fusion of the mandibular processes. The mandible in particular has the most differential typical growth anomalies than any other bone in the human skeleton. This is due to variants in the complex symmetrical growth pattern which formulates the mandible.

<span class="mw-page-title-main">Panoramic radiograph</span> Type of X-ray

A panoramic radiograph is a panoramic scanning dental X-ray of the upper and lower jaw. It shows a two-dimensional view of a half-circle from ear to ear. Panoramic radiography is a form of focal plane tomography; thus, images of multiple planes are taken to make up the composite panoramic image, where the maxilla and mandible are in the focal trough and the structures that are superficial and deep to the trough are blurred.

<span class="mw-page-title-main">C-terminal telopeptide</span> Chemical compound

The C-terminal telopeptide (CTX), also known as carboxy-terminal collagen crosslinks, is the C-terminal telopeptide of fibrillar collagens such as collagen type I and type II. It is used as a biomarker in the serum to measure the rate of bone turnover. It can be useful in assisting clinicians to determine a patient's nonsurgical treatment response as well as evaluate a patient's risk of developing complications during healing following surgical intervention. The test used to detect the CTX marker is called the Serum CrossLaps, and it is more specific to bone resorption than any other test currently available.

Atypical facial pain (AFP) is a type of chronic facial pain which does not fulfill any other diagnosis. There is no consensus as to a globally accepted definition, and there is even controversy as to whether the term should be continued to be used. Both the International Headache Society (IHS) and the International Association for the Study of Pain (IASP) have adopted the term persistent idiopathic facial pain (PIFP) to replace AFP. In the 2nd Edition of the International Classification of Headache Disorders (ICHD-2), PIFP is defined as "persistent facial pain that does not have the characteristics of the cranial neuralgias ... and is not attributed to another disorder." However, the term AFP continues to be used by the World Health Organization's 10th revision of the International Statistical Classification of Diseases and Related Health Problems and remains in general use by clinicians to refer to chronic facial pain that does not meet any diagnostic criteria and does not respond to most treatments.

<span class="mw-page-title-main">Osteoradionecrosis</span> Osteoradionecrosis is an Acute form of Osteomyelitis

Osteoradionecrosis (ORN) is a serious complication of radiation therapy in cancer treatment where radiated bone becomes necrotic and exposed. ORN occurs most commonly in the mouth during the treatment of head and neck cancer, and can arise over 5 years after radiation. Common signs and symptoms include pain, difficulty chewing, trismus, mouth-to-skin fistulas and non-healing ulcers.

Osteomyelitis of the jaws is osteomyelitis which occurs in the bones of the jaws. Historically, osteomyelitis of the jaws was a common complication of odontogenic infection. Before the antibiotic era, it was frequently a fatal condition.

<span class="mw-page-title-main">Impacted wisdom teeth</span> Teeth that do not fully grow out of the gums due to being blocked by other teeth

Impacted wisdom teeth is a condition where the third molars are prevented from erupting into the mouth. This can be caused by a physical barrier, such as other teeth, or when the tooth is angled away from a vertical position. Completely unerupted wisdom teeth usually result in no symptoms, although they can sometimes develop cysts or neoplasms. Partially erupted wisdom teeth or wisdom teeth that are not erupted but are exposed to oral bacteria through deep periodontal pocket, can develop cavities or pericoronitis. Removal of impacted wisdom teeth is advised for the future prevention of or in the current presence of certain pathologies, such as caries, periodontal disease or cysts. Prophylactic (preventative) extraction of wisdom teeth is preferred to be done at a younger age to take advantage of incomplete root development, which is associated with an easier surgical procedure and less probability of complications.

Parish P. Sedghizadeh is a clinician-scientist, and a clinical and surgical oral and maxillofacial pathologist. He is a Professor of Clinical Dentistry, and Section Chair of Diagnostic Sciences in the Division of Periodontology, Diagnostic Sciences & Dental Hygiene at the Herman Ostrow School of Dentistry, University of Southern California. He is also the Director of the Oral Pathology and Radiology Distance Learning Program at the University of Southern California.

References

  1. 1 2 3 4 Hughes, J. P; Baron, R; Buckland, D. H; Cooke, M. A; Craig, J. D; Duffield, D. P; Grosart, A. W; Parkes, P. W; Porter, A (1962). "Phosphorus Necrosis of the Jaw: A Present-Day Study: With Clinical and Biochemical Studies". British Journal of Industrial Medicine. 19 (2): 83–99. doi:10.1136/oem.19.2.83. JSTOR   27721724. PMC   1038164 . PMID   14449812.
  2. 1 2 3 4 Jacobsen, C; Zemann, W; Obwegeser, J. A; Grätz, K. W; Metzler, P (2014). "The phosphorus necrosis of the jaws and what can we learn from the past" (PDF). Oral and Maxillofacial Surgery. 18 (1): 31–7. doi:10.1007/s10006-012-0376-z. PMID   23271457. S2CID   22798482.
  3. 1 2 3 Marx, Robert E (2008). "Uncovering the Cause of "Phossy Jaw" Circa 1858 to 1906: Oral and Maxillofacial Surgery Closed Case Files—Case Closed". Journal of Oral and Maxillofacial Surgery. 66 (11): 2356–63. doi:10.1016/j.joms.2007.11.006. PMID   18940506.
  4. "Workshops of Horror". New Zealand Department of Labour. Archived from the original on 20 June 2007.
  5. Chustecka, Zosia (2005). "Bisphosphonates and jaw osteonecrosis". Medscape.
  6. Pollock, RA; Brown TW, Jr; Rubin, DM (September 2015). ""Phossy Jaw" and "Bis-phossy Jaw" of the 19th and the 21st Centuries: The Diuturnity of John Walker and the Friction Match". Craniomaxillofacial Trauma & Reconstruction. 8 (3): 262–70. doi:10.1055/s-0035-1558452. PMC   4812794 . PMID   27053988.
  7. Hellstein, J. W; Marek, C. L (2004). "Bis-phossy jaw, phossy jaw, and the 21st century: Bisphosphonate-associated complications of the jaws". Journal of Oral and Maxillofacial Surgery. 62 (12): 1563–5. doi:10.1016/j.joms.2004.09.004. PMID   15573361.
  8. Jacobsen, C. "The phosphorous necrosis of the jaws and what can we learn from the past: a comparison of "phossy" and "bisphossy" jaw" (PDF). Retrieved 27 November 2022.
  9. 1 2 3 4 5 Lee, R. Alton (1966). "The Eradication of Phossy Jaw: A Unique Development Of Federal Police Power". The Historian. 29: 1–21. doi:10.1111/j.1540-6563.1966.tb01764.x.
  10. "The Return of the Dreaded Phossy Jaw". RDH Magazine. July 2009.
  11. 1 2 3 4 5 Myers, M. L; McGlothlin, J. D (1996). "Matchmakers' "phossy jaw" eradicated". American Industrial Hygiene Association Journal. 57 (4): 330–2. PMID   8901233.
  12. 1 2 "Phosphorus Poisoning in the Match Industry in the United States". JAMA. 303 (22): 2303. 2010. doi:10.1001/jama.2010.696.
  13. 1 2 Fact and fiction about Salvation Army history. salvationarmy.org.au Archived August 19, 2008, at the Wayback Machine
  14. Phossy jaw. Rootsweb.com. Retrieved on 2018-04-12.
  15. Durie BG; Katz M; Crowley J (July 2005). "Osteonecrosis of the jaw and bisphosphonates". N. Engl. J. Med. 353 (1): 99–102, discussion 99–102. doi:10.1056/NEJM200507073530120. PMID   16000365.
  16. Abu-Id, Mario H; Warnke, Patrick H; Gottschalk, Joachim; Springer, Ingo; Wiltfang, Jörg; Acil, Yahya; Russo, Paul A.J; Kreusch, Thomas (2008). ""Bis-phossy jaws" – High and low risk factors for bisphosphonate-induced osteonecrosis of the jaw". Journal of Cranio-Maxillofacial Surgery. 36 (2): 95–103. doi:10.1016/j.jcms.2007.06.008. PMID   18234504.
  17. Cartsos VM, Zhu S, Zavras AI (January 2008). "Bisphosphonate use and the risk of adverse jaw outcomes: a medical claims study of 714,217 people". J Am Dent Assoc. 139 (1): 23–30. doi:10.14219/jada.archive.2008.0016. PMID   18167381.